SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-017638
Filing Date
2021-07-23
Accepted
2021-07-23 16:30:15
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 795494
2 ex31-1.htm EX-31.1 12639
3 ex32-1.htm EX-32.1 4521
  Complete submission text file 0001493152-21-017638.txt   7815243

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nhpc-20200331.xml EX-101.INS 1213370
5 XBRL SCHEMA FILE nhpc-20200331.xsd EX-101.SCH 59651
6 XBRL CALCULATION FILE nhpc-20200331_cal.xml EX-101.CAL 69817
7 XBRL DEFINITION FILE nhpc-20200331_def.xml EX-101.DEF 282001
8 XBRL LABEL FILE nhpc-20200331_lab.xml EX-101.LAB 423965
9 XBRL PRESENTATION FILE nhpc-20200331_pre.xml EX-101.PRE 372132
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 211111213
SIC: 2833 Medicinal Chemicals & Botanical Products